Description of Medical ServiceThe MBS item 73338 tests tumour tissue from a patient with metastatic colorectal cancer (stage IV) to determine if the requirements relating to rat sarcoma oncogene (RAS) gene mutation status for access to certain Pharmaceutical Benefits Scheme (PBS) medicines are fulfilled. This application seeks to amend item 73338 to include testing for BRAF V600 mutation status to determine eligibility for PBS access to encorafenib for metastatic colorectal cancer.
Reason for ApplicationAmendment to MBS item
Medical Service TypeCo-dependent technology
Previous Application Number/sNot Applicable
Application FormApplication Form (PDF 1197 KB)
Application Form (Word 212 KB)
Consultation SurveyConsultation Survey (PDF 561 KB)
Consultation Survey (Word 70 KB)